B. A. Stone - JoVE Visualize

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Nucleic Acids Research|May 15, 1996

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide librariesS P Ho, D H Britton, B A Stone, et al.

Cancer Research|July 1, 1987

Tumor-specific genetically engineered murine/human chimeric monoclonal antibodyB A Brown, G L Davis, J Saltzgaber-Muller, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986

A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigenB G Sahagan, H Dorai, J Saltzgaber-Muller, et al.

Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Nucleic Acids Research|May 15, 1996

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide librariesS P Ho, D H Britton, B A Stone, et al.

Cancer Research|July 1, 1987

Tumor-specific genetically engineered murine/human chimeric monoclonal antibodyB A Brown, G L Davis, J Saltzgaber-Muller, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986

A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigenB G Sahagan, H Dorai, J Saltzgaber-Muller, et al.

Pageof 7